• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药效团的研究:用于鉴定潜在新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的计算机模拟视角

Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors.

作者信息

Alkhatabi Heba Ahmed, Alatyb Hisham N

机构信息

Faculty of Applied Medical Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Hematology Research Unit (HRU), King Fahd Medical Research Center (KFMRC), Jeddah 80200, Saudi Arabia.

出版信息

Pharmaceuticals (Basel). 2024 Sep 9;17(9):1183. doi: 10.3390/ph17091183.

DOI:10.3390/ph17091183
PMID:39338345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11435111/
Abstract

In the ongoing battle against antibiotic-resistant bacteria, New Delhi metallo-β-lactamase-1 (NDM-1) has emerged as a significant therapeutic challenge due to its ability to confer resistance to a broad range of β-lactam antibiotics. This study presents a pharmacophore-based virtual screening, docking, and molecular dynamics simulation approach for the identification of potential inhibitors targeting NDM-1, a critical enzyme associated with antibiotic resistance. Through the generation of a pharmacophore model and subsequent virtual screening of compound libraries, candidate molecules (ZINC29142850 (Z1), ZINC78607001 (Z2), and ZINC94303138 (Z3)) were prioritized based on their similarity to known NDM-1 binder (hydrolyzed oxacillin (0WO)). Molecular docking studies further elucidated the binding modes and affinities of the selected compounds towards the active site of NDM-1. These compounds demonstrated superior binding affinities to the enzyme compared to a control compound (-7.30 kcal/mol), with binding scores of -7.13, -7.92, and -8.10 kcal/mol, respectively. Binding interactions within NDM-1's active site showed significant interactions with critical residues such as His250, Asn220, and Trp93 for these compounds. Subsequent molecular dynamics simulations were conducted to assess the stability of the ligand-enzyme complexes, showing low root mean square deviation (RMSD) values between 0.5 and 0.7 nm for Z1, Z2, which indicate high stability. Z2's compactness in principal component analysis (PCA) suggests that it can stabilize particular protein conformations more efficiently. Z2 displays a very cohesive landscape with a notable deep basin, suggesting a very persistent conformational state induced by the ligand, indicating robust binding and perhaps efficient inhibition. Z2 demonstrates the highest binding affinity among the examined compounds with a binding free energy of -25.68 kcal/mol, suggesting that it could offer effective inhibition of NDM-1. This study highlights the efficacy of computational tools in identifying novel antimicrobial agents against resistant bacteria, accelerating drug discovery processes.

摘要

在对抗耐抗生素细菌的持续斗争中,新德里金属β-内酰胺酶-1(NDM-1)因其能使细菌对多种β-内酰胺抗生素产生耐药性而成为一个重大的治疗挑战。本研究提出了一种基于药效团的虚拟筛选、对接和分子动力学模拟方法,用于识别靶向NDM-1的潜在抑制剂,NDM-1是一种与抗生素耐药性相关的关键酶。通过生成药效团模型并随后对化合物库进行虚拟筛选,根据候选分子(ZINC29142850(Z1)、ZINC78607001(Z2)和ZINC94303138(Z3))与已知NDM-1结合剂(水解苯唑西林(0WO))的相似性对其进行了优先级排序。分子对接研究进一步阐明了所选化合物与NDM-1活性位点的结合模式和亲和力。与对照化合物(-7.30千卡/摩尔)相比,这些化合物对该酶表现出更高的结合亲和力,结合分数分别为-7.13、-7.92和-8.10千卡/摩尔。NDM-1活性位点内的结合相互作用显示,这些化合物与关键残基如His250、Asn220和Trp93有显著相互作用。随后进行分子动力学模拟以评估配体-酶复合物的稳定性,Z1、Z2的均方根偏差(RMSD)值在0.5至0.7纳米之间,表明稳定性较高。Z2在主成分分析(PCA)中的紧凑性表明它可以更有效地稳定特定的蛋白质构象。Z2显示出非常紧密的态势,有一个明显的深谷,表明由配体诱导的构象状态非常持久,表明结合牢固且可能抑制有效。Z2在所研究的化合物中表现出最高的结合亲和力,结合自由能为-25.68千卡/摩尔,表明它可以有效抑制NDM-1。本研究突出了计算工具在识别针对耐药细菌的新型抗菌剂、加速药物发现过程方面的功效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/2c70d4d402c3/pharmaceuticals-17-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/f5125e3fbd29/pharmaceuticals-17-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/ee5d754428d8/pharmaceuticals-17-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/2d9c3045ad38/pharmaceuticals-17-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/4708af2f615d/pharmaceuticals-17-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/2c70d4d402c3/pharmaceuticals-17-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/f5125e3fbd29/pharmaceuticals-17-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/ee5d754428d8/pharmaceuticals-17-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/2d9c3045ad38/pharmaceuticals-17-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/4708af2f615d/pharmaceuticals-17-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8638/11435111/2c70d4d402c3/pharmaceuticals-17-01183-g005.jpg

相似文献

1
Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors.基于药效团的研究:用于鉴定潜在新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的计算机模拟视角
Pharmaceuticals (Basel). 2024 Sep 9;17(9):1183. doi: 10.3390/ph17091183.
2
Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.利塞膦酸盐和甲氨蝶呤是新德里金属β-内酰胺酶-1(NDM-1)的高亲和力抑制剂:药物再利用方法。
Molecules. 2022 Feb 14;27(4):1283. doi: 10.3390/molecules27041283.
3
Identification of a potential inhibitor for New Delhi metallo-β-lactamase 1 (NDM-1) from FDA approved chemical library- a drug repurposing approach to combat carbapenem resistance.从美国食品药品监督管理局(FDA)批准的化学文库中鉴定新型德里金属β-内酰胺酶1(NDM-1)的潜在抑制剂——一种对抗碳青霉烯耐药性的药物再利用方法。
J Biomol Struct Dyn. 2023 Sep-Oct;41(16):7700-7711. doi: 10.1080/07391102.2022.2123402. Epub 2022 Sep 27.
4
Molecular dynamics simulation studies of novel β-lactamase inhibitor.新型β-内酰胺酶抑制剂的分子动力学模拟研究
J Mol Graph Model. 2017 Jun;74:143-152. doi: 10.1016/j.jmgm.2017.03.002. Epub 2017 Apr 4.
5
Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1).植物化学物质抑制新德里金属β-内酰胺酶(NDM-1)潜力的预测
Pharmaceuticals (Basel). 2023 Oct 3;16(10):1404. doi: 10.3390/ph16101404.
6
Mutations in passive residues modulate 3D-structure of NDM (New Delhi metallo-β-lactamase) protein that endue in drug resistance: a MD simulation approach.非活性残基的突变调节新德里金属β-内酰胺酶(NDM)蛋白的三维结构,该结构赋予耐药性:一种分子动力学模拟方法。
J Biomol Struct Dyn. 2022;40(19):9492-9508. doi: 10.1080/07391102.2021.1930165. Epub 2021 May 26.
7
based unraveling of New Delhi metallo-β-lactamase (NDM-1) inhibitors from natural compounds: a molecular docking and molecular dynamics simulation study.基于天然化合物的新型德里金属-β-内酰胺酶(NDM-1)抑制剂的结构解析:分子对接和分子动力学模拟研究。
J Biomol Struct Dyn. 2020 Apr;38(7):2093-2103. doi: 10.1080/07391102.2019.1627248. Epub 2019 Jun 11.
8
High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.高通量虚拟筛选、分子动力学模拟和酶动力学鉴定 ZINC84525623 为 NDM-1 的潜在抑制剂。
Int J Mol Sci. 2019 Feb 14;20(4):819. doi: 10.3390/ijms20040819.
9
Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.利用计算机模拟和体外实验方法鉴定新型德里金属-β-内酰胺酶-1(NDM-1)的潜在抑制剂(MCULE-8777613195-0-12)。
Molecules. 2022 Sep 13;27(18):5930. doi: 10.3390/molecules27185930.
10
Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds.从一系列抗菌天然化合物中寻找针对新德里金属β-内酰胺酶1的潜在抑制剂。
J Nat Sci Biol Med. 2013 Jan;4(1):51-6. doi: 10.4103/0976-9668.107260.

引用本文的文献

1
Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors.基于结构的虚拟筛选、分子对接和分子动力学模拟研究:一种用于鉴定潜在MBL抑制剂的计算机模拟方法。
PLoS One. 2025 Jul 31;20(7):e0324836. doi: 10.1371/journal.pone.0324836. eCollection 2025.

本文引用的文献

1
Differentiating stable and unstable protein using convolution neural network and molecular dynamics simulations.利用卷积神经网络和分子动力学模拟区分稳定和不稳定的蛋白质。
Comput Biol Chem. 2024 Jun;110:108081. doi: 10.1016/j.compbiolchem.2024.108081. Epub 2024 Apr 20.
2
Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1).植物化学物质抑制新德里金属β-内酰胺酶(NDM-1)潜力的预测
Pharmaceuticals (Basel). 2023 Oct 3;16(10):1404. doi: 10.3390/ph16101404.
3
PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against producing NDM-1.
PHT427作为一种有效的新型德里金属β-内酰胺酶-1(NDM-1)抑制剂,恢复了美罗培南对产NDM-1菌株的敏感性。
Front Microbiol. 2023 Apr 17;14:1168052. doi: 10.3389/fmicb.2023.1168052. eCollection 2023.
4
Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.利塞膦酸盐和甲氨蝶呤是新德里金属β-内酰胺酶-1(NDM-1)的高亲和力抑制剂:药物再利用方法。
Molecules. 2022 Feb 14;27(4):1283. doi: 10.3390/molecules27041283.
5
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants.酶抑制剂:应对超级细菌 NDM-1 及其变体的最佳策略。
Int J Mol Sci. 2021 Dec 24;23(1):197. doi: 10.3390/ijms23010197.
6
gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS.gmx_MMPBSA:一种使用GROMACS进行终态自由能计算的新工具。
J Chem Theory Comput. 2021 Oct 12;17(10):6281-6291. doi: 10.1021/acs.jctc.1c00645. Epub 2021 Sep 29.
7
MMFF VI. MMFF94s option for energy minimization studies.MMFF VI。用于能量最小化研究的MMFF94s选项。
J Comput Chem. 1999 May;20(7):720-729. doi: 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X.
8
Differential Consistency Analysis: Which Similarity Measures can be Applied in Drug Discovery?差异一致性分析:药物发现中可应用哪些相似性度量指标?
Mol Inform. 2021 Jul;40(7):e2060017. doi: 10.1002/minf.202060017. Epub 2021 Apr 23.
9
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo--lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.发现硫代氨基脲衍生物作为有效的新型德里金属β-内酰胺酶-1(NDM-1)抑制剂,可对抗产生NDM-1的临床分离株。
Acta Pharm Sin B. 2021 Jan;11(1):203-221. doi: 10.1016/j.apsb.2020.07.005. Epub 2020 Jul 16.
10
Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.从天然化合物中发现针对新德里金属β-内酰胺酶 1 的潜在抑制剂:基于计算机的方法。
Sci Rep. 2021 Jan 27;11(1):2390. doi: 10.1038/s41598-021-82009-6.